arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Vaxcyte, Inc.

PCVX

$56.90 ▲ +0.40 (+0.70%) at close

9 Visible periods

21 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Vaxcyte, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $7.7B

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -27.2% ↘

FCF / Share $-4.92 ↘

Trailing P/E —

Price / Book 2.8x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 24, 2026.

9-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-766.63M

↓ -65.2% —

FCF / Share Free cash flow per share

$-4.92

↓ -26.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Cash Quality ↓

Dividend History

Dividend / share · sourced from SEC filings

$0.00 Latest / share

FY 2017

FY 2018

FY 2019

$0.00

FY 2020

$0.00

FY 2021

$0.00

FY 2022

$0.00

FY 2023

$0.00

FY 2024

$0.00

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
EPS Growth YoY (%)	-48.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	8.2% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-20.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-78.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-65.2% Weak ↑ Weak Improving Year-over-year change in net income	-15.3% Weak ↑ Weak Improving Year-over-year change in net income	-80.0% Weak ↓ Weak Declining Year-over-year change in net income	-123.3% Weak ↓ Weak Declining Year-over-year change in net income	-12.2% Weak ↑ Weak Improving Year-over-year change in net income	-77.5% Weak Weak Year-over-year change in net income	-70.5% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-26.3% Weak ↓ Weak Declining Year-over-year change in free cash flow	-20.9% Weak ↓ Weak Declining Year-over-year change in free cash flow	-18.4% Weak Weak Year-over-year change in free cash flow	-10.4% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
FCF / Net Income (x)	0.87x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.28x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	-27.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	40.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	48.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-30.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-33.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-82.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-28.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-290%)	-14.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-194%)	-32.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-316%)	-23.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-256%)	-35.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-335%)	-25.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-272%)	47.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+215%)	51.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+241%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Interest Coverage (x)	—	—	—	-116128.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-14810.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-12797.29x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1353.83x Weak Weak Operating income divided by interest expense Optimal: > 5x	-473.77x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-173.96M	$-387.88M	$-397.45M	$-834.66M	$-68.98M	$-386.20M	$-58.98M	—	—

📊 What does each share earn? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Basic EPS, GAAP (USD)	$-5.63	$-3.80	$-4.14	$-3.44	$-1.93	—	—	—	—
Free Cash Flow per Share (USD)	$-4.92	$-3.89	$-3.22	$-2.72	$-2.46	—	—	—	—
Dividend per Share (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	—	—
Book Value per Share (USD)	$20.49	$26.47	$13.01	$12.00	$5.36	$6.77	$-26.20	—	—
Tangible Book Value per Share (USD)	$20.49	$26.47	$13.01	$12.00	$5.36	$6.77	$-26.20	—	—
Basic Weighted Avg Shares (shares)	136.09M	122.00M	97.16M	64.88M	51.92M	—	—	—	—
Dividend Payout Ratio (%)	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Working Capital (USD)	$1.42B	$1.65B	$950.62M	$902.03M	$227.63M	$342.14M	$50.67M	—	—
Total Equity (USD)	$2.69B	$3.31B	$1.24B	$953.61M	$284.02M	$345.84M	$-106.37M	$-57.73M	$-29.13M

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Depreciation Expense (USD)	$16.40M	$7.00M	$3.16M	$2.58M	$1.80M	$1.41M	$1.23M	$1.04M	—
Net Income, GAAP (USD)	$-766.63M	$-463.93M	$-402.27M	$-223.49M	$-100.08M	$-89.22M	$-50.27M	$-29.48M	—
Operating Cash Flow (USD)	$-655.58M	$-452.63M	$-296.79M	$-170.60M	$-121.39M	$-46.63M	$-47.15M	$-30.47M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 9 years · 32 quarters

Vaxcyte, Inc.

Analytical Summary

9-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare PCVX with peers